The 340B Drug Pricing Program was designed to help safety net providers serve low-income patients, but it has since ballooned into a multibillion-dollar system dominated by large health systems — with ...

The Trump administration has approved eight drugmakers' rebate plans for a controversial 340B drug discount pilot program that kicks off Jan. 1. The 340B Rebate Model Pilot Program, unveiled this ...

WATKINSVILLE, GA / ACCESS Newswire / October 28, 2025 / Rural hospitals in the 340B program are about to feel a new financial pressure. On January 1, 2026, HRSA's 340B Rebate Model Pilot Program will ...

Lawmakers impatient with the lack of progress on a key health care issue — the long-debated need for changes to what’s known as the 340B drug pricing program — say they are closing in on legislation ...

Charlene MacDonald, executive vice president of the Federation of American Hospitals, pushed back against implications made during an Oct. 23 Senate hearing on the federal 340B drug pricing program.

The Health Resources and Services Administration posted on its website that it had approved eight drug company plans for participation in the 340B Rebate Model Pilot Program with a start date of Jan.

The 340B Drug Pricing Program was originally constructed so safety-net health care facilities could stretch scarce resources in caring for low-income patients. However, the program has experienced ...

Guideline supports consistent application of GS1 standards to improve data accuracy and visibility in the healthcare supply ...

Large hospital networks abuse the federal 340B drug discount program that was intended to boost small providers. Facebook/Senator Jerry Moran As an advocate for Kansans living with mental health ...

For the 5,000 people in Illinois living with sickle cell disease, access to affordable medical care and life-saving treatments is necessary. Yet far too many still struggle to get the medications and ...

As the Trump administration prepares to force its Most Favored Nation price controls on drug makers, a major U.S. lobbying group is pushing for a change to drug discounts law that would necessitate a ...